Literature DB >> 21504903

Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.

Mónica Kisic1, Tania Matamoros, María Nevot, Jesús Mendieta, Javier Martinez-Picado, Miguel A Martínez, Luis Menéndez-Arias.   

Abstract

Single amino acid deletions in the β3-β4 hairpin loop of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) have been identified in heavily treated patients. The deletion of Asp-67 together with mutations T69G and K70R (Δ67 complex) are usually associated with thymidine analog resistance mutations (TAMs) (e.g. M41L, T215Y, etc.) while the deletion of Thr-69 (Δ69) is rarely found in isolates containing TAMs. Here, we show that the complex Δ67/T69G/K70R enhances ATP-dependent phosphorolytic activity on primers terminated with 3'-azido-3'-deoxythymidine (AZT) or 2',3'-didehydro-2',3'-dideoxythymidine (d4T) both in the presence or absence of TAMs (i.e. M41L/T215Y), while Δ69 (or the complex S68G/Δ69/K70G) antagonize the effects of TAMs in ATP-mediated excision. These effects are consistent with AZT susceptibility data obtained with recombinant HIV-1 bearing the relevant RTs. Molecular dynamics studies based on models of wild-type HIV-1 RT and mutant Δ69, Δ67/T69G/K70R, and D67N/K70R RTs support a relevant role for Lys/Arg-70 in the excision reaction. In Δ69 RT, the side chain of Lys-70 locates away from the putative pyrophosphate binding site. Therefore, its participation in interactions required for the excision reaction is unlikely. Our theoretical studies also suggest a role for Lys-219 in thymidine analog excision/discrimination. However, pre-steady-state kinetics revealed only minor differences in selectivity of AZT-triphosphate versus dTTP between deletion-containing RTs and their homologous enzymes having the K219E mutation. K219E reduced both ATP- and pyrophosphate-mediated excision of primers terminated with thymidine analogues, only when introduced in RTs bearing Δ69 or S68G/Δ69/K70G, providing further biochemical evidence that explains the lack of association of Δ69 and TAMs in HIV-1 isolates.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504903      PMCID: PMC3121480          DOI: 10.1074/jbc.M111.226100

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  The influence of natural substrates and inhibitors on the nucleotide-dependent excision activity of HIV-1 reverse transcriptase in the infected cell.

Authors:  Anthony James Smith; Walter Alvin Scott
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 2.  Insertions and deletions in HIV-1 reverse transcriptase: consequences for drug resistance and viral fitness.

Authors:  Luis Menéndez-Arias; Tania Matamoros; Clara E Cases-González
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

3.  Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure.

Authors:  Gilberto Betancor; Maria C Puertas; María Nevot; César Garriga; Miguel A Martínez; Javier Martinez-Picado; Luis Menéndez-Arias
Journal:  Antimicrob Agents Chemother       Date:  2010-08-23       Impact factor: 5.191

4.  A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase.

Authors:  P R Meyer; S E Matsuura; A M Mian; A G So; W A Scott
Journal:  Mol Cell       Date:  1999-07       Impact factor: 17.970

5.  Thymidine analogue mutation profiles: factors associated with acquiring specific profiles and their impact on the virological response to therapy.

Authors:  Alessandro Cozzi-Lepri; Lidia Ruiz; Clive Loveday; Andrew N Phillips; Bonaventura Clotet; Peter Reiss; Bruno Ledergerber; Christian Holkmann; Schlomo Staszewski; Jens D Lundgren
Journal:  Antivir Ther       Date:  2005

6.  Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region.

Authors:  Cristina Villena; Julia G Prado; Maria Carmen Puertas; Miguel Angel Martínez; Bonaventura Clotet; Lidia Ruiz; Neil T Parkin; Luis Menéndez-Arias; Javier Martinez-Picado
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

7.  Suppression of multidrug-resistant HIV-1 reverse transcriptase primer unblocking activity by alpha-phosphate-modified thymidine analogues.

Authors:  Tania Matamoros; Jérôme Deval; Catherine Guerreiro; Laurence Mulard; Bruno Canard; Luis Menéndez-Arias
Journal:  J Mol Biol       Date:  2005-04-19       Impact factor: 5.469

8.  Mutational patterns associated with the 69 insertion complex in multi-drug-resistant HIV-1 reverse transcriptase that confer increased excision activity and high-level resistance to zidovudine.

Authors:  Clara E Cases-González; Sandra Franco; Miguel Angel Martínez; Luis Menéndez-Arias
Journal:  J Mol Biol       Date:  2006-10-04       Impact factor: 5.469

Review 9.  Insertions in the beta3-beta4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity.

Authors:  Dirk Eggink; Marleen C D G Huigen; Charles A B Boucher; Matthias Götte; Monique Nijhuis
Journal:  Antiviral Res       Date:  2007-03-26       Impact factor: 5.970

10.  Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3'-azido-3'-dideoxythymidine.

Authors:  Jessica H Brehm; Dianna Koontz; Jeffrey D Meteer; Vinay Pathak; Nicolas Sluis-Cremer; John W Mellors
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

View more
  6 in total

1.  Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection.

Authors:  Anne Derache; Carole L Wallis; Saran Vardhanabhuti; John Bartlett; Nagalingeswaran Kumarasamy; David Katzenstein
Journal:  J Infect Dis       Date:  2015-07-14       Impact factor: 5.226

2.  Formation of a quaternary complex of HIV-1 reverse transcriptase with a nucleotide-competing inhibitor and its ATP enhancer.

Authors:  Maryam Ehteshami; Monique Nijhuis; Jean A Bernatchez; Christopher J Ablenas; Suzanne McCormick; Dorien de Jong; Dirk Jochmans; Matthias Götte
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

3.  Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.

Authors:  Mar Álvarez; María Nevot; Jesús Mendieta; Miguel A Martínez; Luis Menéndez-Arias
Journal:  J Biol Chem       Date:  2017-12-22       Impact factor: 5.157

4.  Changes in codon-pair bias of human immunodeficiency virus type 1 have profound effects on virus replication in cell culture.

Authors:  Gloria Martrus; Maria Nevot; Cristina Andres; Bonaventura Clotet; Miguel Angel Martinez
Journal:  Retrovirology       Date:  2013-07-25       Impact factor: 4.602

5.  NucAmino: a nucleotide to amino acid alignment optimized for virus gene sequences.

Authors:  Philip L Tzou; Xiaoqiu Huang; Robert W Shafer
Journal:  BMC Bioinformatics       Date:  2017-03-01       Impact factor: 3.169

6.  Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy.

Authors:  Gilberto Betancor; César Garriga; Maria C Puertas; María Nevot; Lourdes Anta; José L Blanco; M Jesús Pérez-Elías; Carmen de Mendoza; Miguel A Martínez; Javier Martinez-Picado; Luis Menéndez-Arias; José Antonio Iribarren; Estrella Caballero; Esteban Ribera; Josep Maria Llibre; Bonaventura Clotet; Angels Jaén; David Dalmau; José María Gatel; Joaquín Peraire; Francesc Vidal; Carmen Vidal; Melchor Riera; Juan Córdoba; José López Aldeguer; María José Galindo; Félix Gutiérrez; Marta Álvarez; Federico García; Pilar Pérez-Romero; Pompeyo Viciana; Manuel Leal; José Carlos Palomares; Juan Antonio Pineda; Isabel Viciana; Jesús Santos; Patricia Rodríguez; Juan Luis Gómez Sirvent; Carolina Gutiérrez; Santiago Moreno; Mayte Pérez-Olmeda; José Alcamí; Carmen Rodríguez; Jorge del Romero; Angelina Cañizares; José Pedreira; Celia Miralles; Antonio Ocampo; Luis Morano; Antonio Aguilera; Carolina Garrido; Gustavo Manuzza; Eva Poveda; Vicente Soriano
Journal:  Retrovirology       Date:  2012-08-13       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.